Therefore, the present study showed that ZNF132 and ESR1 have comparable or even better diagnostic capability than SEPT9, suggesting that the panel integrating ZNF132, ESR1, and SEPT9 may better serve as a robust non-invasive diagnostic tool for CRC. Here, ZNF132 is linked to colorectal carcinoma.